Peter Thiel is reinforcing his commitment to the growing trend of "corporate Ethereum treasury" investments. A recent Schedule 13G filing with the U.S. Securities and Exchange Commission reveals that entities connected to Thiel's Founders Fund have acquired a 7.5% passive stake in 180 Life Sciences Corp. (Nasdaq: ATNF).
The company is in the process of rebranding itself as ETHZilla and is shifting its business strategy to focus on accumulating Ethereum-related assets.
